Application of MicroRNA in diagnosis and treatment of ovarian cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Banno, Kouji ^a   Yanokura, Megumi ^a   Iida, Miho ^a   Adachi, Masataka ^a   Nakamura, Kanako ^a   Nogami, Yuya ^a   Umene, Kiyoko ^a   Masuda, Kenta ^a   Kisu, Iori ^a   Nomura, Hiroyuki ^a   Kataoka, Fumio ^a   Tominaga, Eiichiro ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; CARBOPLATIN; CISPLATIN; DICER; DNA METHYLTRANSFERASE INHIBITOR; EVEROLIMUS; MICRORNA; MICRORNA 100; MICRORNA 125B1; MICRORNA 140; MICRORNA 141; MICRORNA 145; MICRORNA 15; MICRORNA 16; MICRORNA 199A; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 373; MICRORNA 376C; MICRORNA 429; MICRORNA 520C; MICRORNA LET 7I; RIBONUCLEASE; RIBONUCLEASE 3; UNCLASSIFIED DRUG; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOSENSITIVITY; DISEASE ASSOCIATION; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GRANULOSA CELL; HUMAN; NONHUMAN; OOCYTE MATURATION; OVARY CANCER; OVARY CARCINOMA; OVARY FOLLICLE CELL; OVARY FUNCTION; OVERALL SURVIVAL; PERITONEUM METASTASIS; REVIEW; RNA PROCESSING; UPREGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84900345484     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/232817     Document Type: Review

References (51)

1. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
2. Yahata T., Banzai C., Tanaka K., Niigata Gynecological Cancer Registry, Histology-specific long-term trends in the incidence of ovarian cancer and borderline tumor in Japanese females: a population-based study from 1983 to 2007. Journal of Obstetrics and Gynaecology Research 2012 38 645 650
3. Weiderpas E., Sandin S., Inoue M., Shimazu T., Iwasaki M., Sasazuki S., Sawada N., Yamaji T., Tsugane S., Risk factors for epithelial ovarian cancer in Japan: results from the Japan Public Health Center-based Prospective Study cohort. International Journal of Oncology 2012 40 1 21 30 2-s2.0-84455194018 10.3892/ijo.2011.1194
4. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010. CA: Cancer Journal for Clinicians 2010 60 5 277 300 2-s2.0-77955635233 10.3322/caac.20073
5. Heintz A., Odicino F., Maisonneuve P., Quinn M., Benedet J., Creasman W., Ngan H., Pecorelli S., Beller U., Carcinoma of the Ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynecology and Obstetrics 2006 95 supplement 1 S161 S192 2-s2.0-33845212719 10.1016/S0020-7292(06)60033-7 (Pubitemid 44854933)
6. Shimasaki S., Moore R. K., Erickson G. F., Otsuka F., The role of bone morphogenetic proteins in ovarian function. Reproduction 2003 61 323 337 2-s2.0-0642307723
7. Minegishi T., Kameda T., Hirakawa T., Abe K., Tano M., Ibuki Y., Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms. Clinical Cancer Research 2000 6 7 2764 2770 2-s2.0-0033910864 (Pubitemid 30482116)
8. Mase Y., Ishibashi O., Ishikawa T., Takizawa T., Kiguchi K., Ohba T., Katabuchi H., Takeshita T., Takizawa T., MiR-21 is enriched in the RNA-induced silencing complex and targets COL4A1 in human granulosa cell lines. Reproductive Sciences 2012 19 1030 1040
9. Murchison E. P., Stein P., Xuan Z., Pan H., Zhang M. Q., Schultz R. M., Hannon G. J., Critical roles for Dicer in the female germline. Genes and Development 2007 21 6 682 693 2-s2.0-33947306584 10.1101/gad.1521307 (Pubitemid 46440290)
10. Iorio M. V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.-G., Alder H., Calin G. A., Ménard S., Croce C. M., MicroRNA signatures in human ovarian cancer. Cancer Research 2007 67 18 8699 8707 2-s2.0-34548746977 10.1158/0008-5472.CAN-07-1936 (Pubitemid 47437445)
11. Bracken C. P., Gregory P. A., Kolesnikoff N., Bert A. G., Wang J., Shannon M. F., Goodall G. J., A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Research 2008 68 19 7846 7854 2-s2.0-54049084380 10.1158/0008-5472.CAN-08-1942
12. Merritt W. M., Lin Y. G., Han L. Y., Kamat A. A., Spannuth W. A., Schmandt R., Urbauer D., Pennacchio L. A., Cheng J.-F., Nick A. M., Deavers M. T., Mourad-Zeidan A., Wang H., Mueller P., Lenburg M. E., Gray J. W., Mok S., Birrer M. J., Lopez-Berestein G., Coleman R. L., Bar-Eli M., Sood A. K., Dicer, Drosha, and outcomes in patients with ovarian cancer. The New England Journal of Medicine 2008 359 25 2641 2650 2-s2.0-58049213696 10.1056/NEJMoa0803785
13. Hong L., Yang Z., Ma J., Fan D., Function of miRNA in controlling drug resistance of human cancers. Current Drug Targets 2013 14 1118 1127
14. Yang N., Kaur S., Volinia S., Greshock J., Lassus H., Hasegawa K., Liang S., Leminen A., Deng S., Smith L., Johnstone C. N., Chen X. M., Liu C. G., Huang Q., Katsaros D., Calin G. A., Weber B. L., Bützow R., Croce C. M., Coukos G., Zhang L., MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Research 2004 10 2687 2693
15. Mitamura T., Watari H., Wang L., Kanno H., Hassan M. K., Miyazaki M., Katoh Y., Kimura T., Tanino M., Nishihara H., Tanaka S., Sakuragi N., Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogenesis 2013 2, article e40
16. Aqeilan R. I., Calin G. A., Croce C. M., MiR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death and Differentiation 2010 17 2 215 220 2-s2.0-74249084440 10.1038/cdd.2009.69
17. Leskelä S., Leandro-García L. J., Mendiola M., Barriuso J., Inglada-Pérez L., Muñoz I., Martínez-Delgado B., Redondo A., De Santiago J., Robledo M., Hardisson D., Rodríguez-Antona C., The miR-200 family controls β -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocrine-Related Cancer 2011 18 1 85 95 2-s2.0-79251476882 10.1677/ERC-10-0148
18. Boyerinas B., Park S.-M., Murmann A. E., Gwin K., Montag A. G., Zillhardt M., Hua Y.-J., Lengyel E., Peter M. E., Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1. International Journal of Cancer 2012 130 8 1787 1797 2-s2.0-84857503465 10.1002/ijc.26190
19. Lu L., Schwartz P., Scarampi L., Rutherford T., Canuto E. M., Yu H., Katsaros D., MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management. Gynecologic Oncology 2011 122 2 366 371 2-s2.0-79960472021 10.1016/j.ygyno.2011.04.033
20. Nagaraja A. K., Creighton C. J., Yu Z., Zhu H., Gunaratne P. H., Reid J. G., Olokpa E., Itamochi H., Ueno N. T., Hawkins S. M., Anderson M. L., Matzuk M. M., A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Molecular Endocrinology 2010 24 2 447 463 2-s2.0-75149146772 10.1210/me.2009-0295
21. Peng D.-X., Luo M., Qiu L.-W., He Y.-L., Wang X.-F., Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Oncology Reports 2012 27 4 1238 1244 2-s2.0-84856583656 10.3892/or.2012.1625
22. Fu X., Tian J., Zhang L., Chen Y., Hao Q., Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Letters 2012 586 9 1279 1286 2-s2.0-84860335557 10.1016/j.febslet.2012.03.006
23. van Jaarsveld M. T. M., Helleman J., Berns E. M. J. J., Wiemer E. A. C., MicroRNAs in ovarian cancer biology and therapy resistance. International Journal of Biochemistry and Cell Biology 2010 42 8 1282 1290 2-s2.0-77952671554 10.1016/j.biocel.2010.01.014
24. Laios A., O'Toole S., Flavin R., Martin C., Kelly L., Ring M., Finn S. P., Barrett C., Loda M., Gleeson N., D'Arcy T., McGuinness E., Sheils O., Sheppard B., O'Leary J., Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Molecular Cancer 2008 7, article 35 2-s2.0-43949136141 10.1186/1476-4598-7-35 (Pubitemid 351699620)
25. Nam E. J., Yoon H., Kim S. W., Kim H., Kim Y. T., Kim J. H., Kim J. W., Kim S., MicroRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 2008 14 9 2690 2695 2-s2.0-50849137458 10.1158/1078-0432.CCR-07- 1731
26. Zhang L., Volinia S., Bonome T., Calin G. A., Greshock J., Yang N., Liu C.-G., Giannakakis A., Alexiou P., Hasegawa K., Johnstone C. N., Megraw M. S., Adams S., Lassus H., Huang J., Kaur S., Liang S., Sethupathy P., Leminen A., Simossis V. A., Sandaltzopoulos R., Naomoto Y., Katsaros D., Gimotty P. A., DeMichele A., Huang Q., Bützow R., Rustgi A. K., Weber B. L., Birrer M. J., Hatzigeorgiou A. G., Croce C. M., Coukos G., Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 19 7004 7009 2-s2.0-44349124725 10.1073/pnas.0801615105 (Pubitemid 351754520)
27. Eitan R., Kushnir M., Lithwick-Yanai G., David M. B., Hoshen M., Glezerman M., Hod M., Sabah G., Rosenwald S., Levavi H., Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecologic Oncology 2009 114 2 253 259 2-s2.0-67549139894 10.1016/j.ygyno.2009.04.024
28. Gallagher M. F., Flavin R. J., Elbaruni S. A., McInerney J. K., Smyth P. C., Salley Y. M., Vencken S. F., O'Toole S. A., Laios A., Lee M. Y., Denning K., Li J., Aherne S. T., Lao K. Q., Martin C. M., Sheils O. M., O'Leary J. J., Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients. Journal of Ovarian Research 2009 2 1, article 19 2-s2.0-77953372578 10.1186/1757-2215-2-19
29. Lee C.-H., Subramanian S., Beck A. H., Espinosa I., Senz J., Zhu S. X., Huntsman D., van de Rijn M., Gilks C. B., MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS ONE 2009 4 10 2-s2.0-70350128013 10.1371/journal.pone.0007314 e7314
30. Wyman S. K., Parkin R. K., Mitchell P. S., Fritz B. R., O'Briant K., Godwin A. K., Urban N., Drescher C. W., Knudsen B. S., Tewari M., Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 2009 4 4 2-s2.0-65349147075 10.1371/journal.pone.0005311 e5311
31. Toloubeydokhti T., Bukulmez O., Chegini N., Potential regulatory functions of MicroRNAs in the ovary. Seminars in Reproductive Medicine 2008 26 6 469 478 2-s2.0-55849147627 10.1055/s-0028-1096127
32. Creighton C. J., Fountain M. D., Yu Z., Nagaraja A. K., Zhu H., Khan M., Olokpa E., Zariff A., Gunaratne P. H., Matzuk M. M., Anderson M. L., Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Research 2010 70 5 1906 1915 2-s2.0-77950202790 10.1158/0008-5472.CAN-09-3875
33. Voorhoeve P. M., le Sage C., Schrier M., Gillis A. J. M., Stoop H., Nagel R., Liu Y.-P., van Duijse J., Drost J., Griekspoor A., Zlotorynski E., Yabuta N., De Vita G., Nojima H., Looijenga L. H. J., Agami R., A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006 124 6 1169 1181 2-s2.0-33646056975 10.1016/j.cell.2006.02.037
34. Yukihiro H., Nozomu Y., Noriko Y., Kazunori O., Aikou O., MicroRNA-21 overexpression through the 17q21-24 amplication regulates PTEN tumor suppressor gene expression in ovarian clear cell carcinoma. Acta Obstetrica Et Gynaecologya Japonica 2013 65, artile 860
35. Garzon R., Marcucci G., Croce C. M., Targeting microRNAs in cancer: rationale, strategies and challenges. Nature Reviews Drug Discovery 2010 9 10 775 789 2-s2.0-77957361864 10.1038/nrd3179
36. Lu Y., Xiao J., Lin H., Bai Y., Luo X., Wang Z., Yang B., A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Research 2009 37 3, article e24 2-s2.0-63349085394 10.1093/nar/gkn1053
37. Dai F., Zhang Y., Zhu X., Shan N., Chen Y., Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation. Targeted Oncology 2012 7 217 225
38. Ohyagi-Hara C., Sawada K., Kamiura S., Tomita Y., Isobe A., Hashimoto K., Kinose Y., Mabuchi S., Hisamatsu T., Takahashi T., Kumasawa K., Nagata S., Morishige K., Lengyel E., Kurachi H., Kimura T., miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin a5 expression. The American Journal of Pathology 2013 182 1876 1889
39. Cittelly D. M., Dimitrova I., Howe E. N., Cochrane D. R., Jean A., Spoelstra N. S., Post M. D., Lu X., Broaddus R. R., Spillman M. A., Richer J. K., Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Molecular Cancer Therapeutics 2012 11 2556 2565
40. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596 (Pubitemid 47214727)
41. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T., Secretory mechanisms and intercellular transfer of microRNAs in living cells. Journal of Biological Chemistry 2010 285 23 17442 17452 2-s2.0-77952920881 10.1074/jbc.M110.107821
42. Kosaka N., Izumi H., Sekine K., Ochiya T., MicroRNA as a new immune-regulatory agent in breast milk. Silence 2010 1 1, article 7 2-s2.0-77957037314 10.1186/1758-907X-1-7
43. Gnyszka A., Jastrzebski Z., Flis S., DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Research 2013 33 2989 2996
44. Walker A. R., Klisovic R. B., Garzon R., Schaaf L. J., Humphries K., Devine S. M., Byrd J. C., Grever M. R., Marcucci G., Blum W., Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia. Leukemia Lymphoma. In press
45. Andrade A. F., Borges K. S., Castro-Gamero A. M., Silveira V. S., Suazo V. K., Oliveira J. C., Moreno D. A., de Paula Queiroz R. G., Scrideli C. A., Tone L. G., Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells. Anticancer Drugs 2014 25 72 81
46. Fang F., Balch C., Schilder J., Breen T., Zhang S., Shen C., Li L., Kulesavage C., Snyder A. J., Nephew K. P., Matei D. E., A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer. Cancer 2010 116 17 4043 4053 2-s2.0-77954121574 10.1002/cncr.25204
47. Sessa C., Ten Bokkel Huinink W., Stoter G., Renards J., Cavalli F., Phase II study of 5-Aza-′-deoxycytidine in advanced ovarian carcinoma. European Journal of Cancer 1990 26 2 137 138 2-s2.0-0025355878 10.1016/0277-5379(90) 90295-5 (Pubitemid 20121864)
48. Matei D., Fang F., Shen C., Schilder J., Arnold A., Zeng Y., Berry W. A., Huang T., Nephew K. P., Epigenetic resensitization to platinum in ovarian cancer. Cancer Research 2012 72 9 2197 2205 2-s2.0-84860528199 10.1158/0008-5472.CAN-11-3909
49. Liu J., Xiao Z., Wong S. K., Tin V. P., Ho K. Y., Wang J., Sham M. H., Wong M. P., Lung cancer tumorigenicity and drug resistance are maintained through ALDHhiCD44hi tumor initiating cells. Oncotarget 2013 4 1686 1699
50. Li B., Cheng X. L., Yang Y. P., Li Z. Q., GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line. Oncology Reports 2013 30 2119 2126
51. Yasuda K., Torigoe T., Morita R., Kuroda T., Takahashi A., Matsuzaki J., Kochin V., Asanuma H., Hasegawa T., Saito T., Hirohashi Y., Sato N., Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population. PLoS ONE 2013 8 e68187